Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients

Oncotarget - United States
doi 10.18632/oncotarget.18150
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR Genetic Polymorphisms on Tacrolimus Metabolism in Chinese Renal Transplant Recipients

PLoS ONE
Multidisciplinary
2014English

Personalized Tacrolimus Dose Requirement by CYP3A5 but Not ABCB1 or ACE Genotyping in Both Recipient and Donor After Pediatric Liver Transplantation

PLoS ONE
Multidisciplinary
2014English

Genotype-Guided Tacrolimus Dosing in African-American Kidney Transplant Recipients

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2015English

Genetic Polymorphisms in CYP3A5 and MDR1 Genes and Their Correlations With Plasma Levels of Tacrolimus and Cyclosporine in Renal Transplant Recipients

Transplantation Proceedings
SurgeryTransplantation
2009English

Effect of CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

The Impact of Tacrolimus Exposure on Extrarenal Adverse Effects in Adult Renal Transplant Recipients

British Journal of Clinical Pharmacology
Pharmacology
2019English

Dosing Recommendations Based on Population Pharmacokinetics of Tacrolimus in Mexican Adult Patients With Kidney Transplant

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

The Relationship Between Tacrolimus Concentration-Dose Ratio and Genetic Polymorphism in Patients Subjected to Renal Transplantation

Vojnosanitetski Pregled
MedicinePharmacology
2018English

Response to "Clinical Relevance of CYP3A5 Genotype on Maraviroc Exposures"

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy